About
Developed the Optejet microdosing dispenser for eye drops (dry eye, myopia). As of 2025–26 the company (now Hyperion DeFi) has pivoted and sought to monetise/sell the Optejet ophthalmic business.
HQ: US
Funding
Public (NASDAQ: HYPD, formerly EYEN)
Pivot/divestiture in progress — verify current status.